3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
34
Uterine Cervical Neoplasms
24
Fallopian Tube Neoplasms
18
Endometrial Neoplasms
16
Neoplasm Metastasis
10
Lung Neoplasms
9
Pancreatic Neoplasms
8
Stomach Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Transitional Cell
7
Breast Neoplasms
7
Melanoma
6
Carcinoma, Renal Cell
6
Prostatic Neoplasms
5
Esophageal Neoplasms
5
Carcinosarcoma
5
Carcinoma, Hepatocellular
5
Vaginal Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Testicular Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Multiple Myeloma
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Vulvar Neoplasms
2
Interventions
pembrolizumab
2
fludarabine
2
SS1(dsFv)PE38
2
Platinum
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cyclophosphamide
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
enzalutamide
1
entinostat
1
X-Rays
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Polymerase Chain Reaction
1
Paclitaxel
1
Nivolumab
1
Microarray Analysis
1
Megestrol Acetate
1
Magnetic Resonance Spectroscopy
1
Levoleucovorin
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
In Situ Hybridization, Fluorescence
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Magnetic Resonance Spectroscopy
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled